Reiterates Planned Cytisinicline NDA Submission Expected at the End of Q2 2025Company to Host Conference Call at 8:30 AM EDT Today, Tuesday, ...

Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development ...

Each cell in your body relies on precise communication with other cells to function properly. At the center of this process ...

Largest safety data set on FcRn blocking demonstrates consistent, favorable safety profileof VYVGART and VYVGART HytrulogMG patients on VYVGART ...

Touch a hot plate and your hand flies back. While the response is almost instant, researchers are still working to better ...

Water and sodium retention during severe hypothyroidism create a state of volume depletion, low extracellular fluid osmolality and increased water retention. The hypothyroid population is ...

umin.ac.jp Nivolumab is a monoclonal antibody to programmed cell death-1 (PD-1) protein and acts as an immune checkpoint inhibitor by disrupting the interaction of the PD-1 receptor with its ligands.